Diseases, Conditions, Syndromes

A year after first death in China, coronavirus source still a puzzle

It is the world's most pressing scientific puzzle, but experts warn there may never be conclusive answers over the source of the coronavirus, after an investigative effort marked from the start by disarray, Chinese secrecy ...

Medical economics

Waiver war at WTO over Covid jab IP rights

The World Trade Organization faces calls led by India and South Africa to waive intellectual property rights for COVID-19 vaccines—a notion fiercely rejected by pharmaceutical giants and their host countries.

Vaccination

Medicago and GSK to begin final Covid-19 vaccine trials

Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.

Diseases, Conditions, Syndromes

Heading off the next pandemic

As the COVID-19 pandemic heads for a showdown with vaccines it's expected to lose, many experts in the field of emerging infectious diseases are already focused on preventing the next one.

Diseases, Conditions, Syndromes

Wuhan marks a year since lockdown as Biden warns of 600,000 dead

The Chinese city of Wuhan marked one year since the start of its traumatic 76-day coronavirus lockdown Saturday while the pandemic continued to rage elsewhere, with US President Joe Biden warning America's death toll could ...

page 2 from 12